First report of heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) causing fatal infection in Hungary. - Suppr | 超能文献

First report of heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) causing fatal infection in Hungary.

作者信息

Tóth A, Kispál Gy, Ungvári E, Violka M, Szeberin Z, Pászti J, Molnár K, Gacs M, Füzi M

出版信息

J Chemother. 2008 Oct;20(5):655-6. doi: 10.1179/joc.2008.20.5.655.

DOI:10.1179/joc.2008.20.5.655

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

First report of heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) causing fatal infection in Hungary.

J Chemother. 2008 Oct;20(5):655-6. doi: 10.1179/joc.2008.20.5.655.

2

Vancomycin, unbeatable for methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia? Really?万古霉素，对耐甲氧西林金黄色葡萄球菌医院获得性肺炎无敌有效？真的吗？

Crit Care Med. 2010 Sep;38(9):1910-2. doi: 10.1097/CCM.0b013e3181f11ad9.

3

Pharmacotherapy for methicillin-resistant Staphylococcus aureus nosocomial pneumonia.耐甲氧西林金黄色葡萄球菌医院获得性肺炎的药物治疗。

Ann Pharmacother. 2012 Dec;46(12):1678-87. doi: 10.1345/aph.1R370. Epub 2012 Dec 11.

4

Molecular epidemiology and clinical characteristics of hetero-resistant vancomycin intermediate Staphylococcus aureus bacteremia in a Taiwan Medical Center.台湾一家医学中心耐异质性万古霉素中介金黄色葡萄球菌菌血症的分子流行病学和临床特征。

J Microbiol Immunol Infect. 2012 Dec;45(6):435-41. doi: 10.1016/j.jmii.2012.05.004. Epub 2012 Jun 30.

5

What is the best therapeutic approach to methicillin-resistant Staphylococcus aureus pneumonia?耐甲氧西林金黄色葡萄球菌肺炎的最佳治疗方法是什么？

Curr Opin Infect Dis. 2015 Apr;28(2):164-70. doi: 10.1097/QCO.0000000000000149.

6

Vancomycin plus rifampicin for methicillin-resistant Staphylococcus aureus pneumonia benefits only those who have no development of rifampicin resistance during treatment.万古霉素联合利福平治疗耐甲氧西林金黄色葡萄球菌肺炎仅对治疗期间未出现利福平耐药的患者有益。

Crit Care Med. 2010 Aug;38(8):1754; author reply 1754-5. doi: 10.1097/CCM.0b013e3181db7d28.

7

Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.万古霉素中介敏感性和异质性耐药在耐甲氧西林金黄色葡萄球菌菌血症中的相关性。

J Antimicrob Chemother. 2011 Jul;66(7):1594-9. doi: 10.1093/jac/dkr169. Epub 2011 Apr 26.

8

Heteroresistance to glycopeptides in Italian meticillin-resistant Staphylococcus aureus (MRSA) isolates.意大利耐甲氧西林金黄色葡萄球菌（MRSA）分离株对糖肽类药物的异质性耐药。

Int J Antimicrob Agents. 2010 Nov;36(5):415-9. doi: 10.1016/j.ijantimicag.2010.06.044. Epub 2010 Aug 19.

9

Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.耐甲氧西林金黄色葡萄球菌所致复杂性皮肤和皮肤结构感染及医院获得性肺炎中体重对治疗效果和安全性的影响。

Clin Ther. 2013 Oct;35(10):1557-70. doi: 10.1016/j.clinthera.2013.08.001. Epub 2013 Sep 3.

10

High vancomycin minimum inhibitory concentrations with heteroresistant vancomycin-intermediate Staphylococcus aureus in meticillin-resistant S. aureus bacteraemia patients.耐甲氧西林金黄色葡萄球菌血流感染患者中存在异质性万古霉素中介金黄色葡萄球菌时，万古霉素最小抑菌浓度较高。

Int J Antimicrob Agents. 2013 Nov;42(5):390-4. doi: 10.1016/j.ijantimicag.2013.07.010. Epub 2013 Aug 23.

引用本文的文献

1

Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis.万古霉素耐药、万古霉素中介和异质性万古霉素中介金黄色葡萄球菌临床分离株的全球流行率和分布：系统评价和荟萃分析。

Sci Rep. 2020 Jul 29;10(1):12689. doi: 10.1038/s41598-020-69058-z.